Nancy L Bartlett Selected Research

Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)

10/2022	Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma.
1/2019	Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
10/2018	Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas.
7/2015	Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.
10/2014	Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study.
1/2012	A phase I weekly dosing study of brentuximab vedotin in patients with relapsed/refractory CD30-positive hematologic malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nancy L Bartlett Research Topics

Disease

66	Hodgkin Disease (Hodgkin's Disease) 11/2023 - 02/2002
45	Lymphoma (Lymphomas) 04/2024 - 08/2003
44	Neoplasms (Cancer) 05/2024 - 05/2002
26	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2024 - 06/2002
26	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023 - 08/2003
22	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 05/2002
22	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 08/2003
13	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2023 - 02/2008
13	Leukemia 11/2020 - 07/2007
12	Neutropenia 12/2023 - 05/2014
11	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2018 - 07/2009
7	Disease Progression 12/2023 - 11/2011
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2024 - 12/2015
6	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2022 - 01/2012
6	Fatigue 06/2020 - 06/2012
6	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 02/2008
5	Exanthema (Rash) 01/2020 - 11/2002
4	Cytokine Release Syndrome 01/2024 - 01/2017
4	Febrile Neutropenia 01/2022 - 01/2017
4	Peripheral Nervous System Diseases (PNS Diseases) 12/2017 - 09/2012
4	Thrombocytopenia (Thrombopenia) 01/2017 - 06/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 01/2018
3	Second Primary Neoplasms (Neoplasms, Second) 10/2023 - 10/2019
3	Nausea 12/2021 - 12/2015
3	Infections 10/2021 - 01/2015
3	Body Weight (Weight, Body) 11/2018 - 11/2010
2	Atrial Fibrillation 01/2024 - 10/2021
2	Hypertension (High Blood Pressure) 01/2024 - 10/2021
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2022 - 05/2012
2	Pancreatitis 01/2021 - 11/2020
2	Multiple Myeloma 12/2020 - 02/2008
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020 - 02/2014
2	Vomiting 10/2019 - 12/2015
2	Diarrhea 10/2019 - 12/2015
2	Bites and Stings (Sting) 06/2019 - 05/2015
2	Progressive Multifocal Leukoencephalopathy 01/2019 - 11/2012
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 05/2015
2	Cough 12/2015 - 01/2015
2	Anemia 12/2015 - 06/2012
2	T-Cell Lymphoma (Lymphoma, T Cell) 07/2015 - 05/2014
2	Mycosis Fungoides 07/2015 - 05/2012

Drug/Important Bio-Agent (IBA)

37	Rituximab (Mabthera)FDA Link 04/2024 - 05/2002
36	Brentuximab VedotinIBA 10/2023 - 07/2008
25	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2006
13	ibrutinibIBA 01/2024 - 12/2015
13	Lenalidomide (CC 5013)FDA Link 09/2023 - 02/2008
13	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 07/2008
13	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 07/2008
12	Immunoconjugates (Immunoconjugate)IBA 11/2023 - 04/2009
12	Monoclonal AntibodiesIBA 05/2023 - 08/2003
12	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 07/2008
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 06/2014
12	Prednisone (Sone)FDA LinkGeneric 11/2021 - 04/2013
11	Vincristine (Oncovin)FDA LinkGeneric 11/2021 - 04/2013
9	Bendamustine Hydrochloride FDA Link 04/2024 - 01/2010
8	Etoposide (VP 16)FDA LinkGeneric 11/2021 - 04/2013
7	axicabtagene ciloleucelIBA 01/2024 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2008
6	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2017
6	NivolumabIBA 12/2021 - 12/2017
5	Bispecific AntibodiesIBA 03/2024 - 05/2015
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2023 - 10/2016
5	AntigensIBA 12/2023 - 04/2009
5	Chimeric Antigen ReceptorsIBA 11/2023 - 12/2017
5	pembrolizumabIBA 01/2023 - 12/2017
5	Bortezomib (Velcade)FDA Link 01/2020 - 07/2007
4	AnthracyclinesIBA 12/2023 - 05/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2021
3	Agammaglobulinaemia Tyrosine KinaseIBA 11/2023 - 02/2016
3	blinatumomabIBA 10/2023 - 05/2015
3	AntibodiesIBA 10/2023 - 08/2003
3	polatuzumab vedotinIBA 10/2023 - 01/2019
3	Histone Deacetylase InhibitorsIBA 03/2016 - 07/2008
3	Gemcitabine FDA Link 05/2011 - 11/2002
3	ibritumomab tiuxetan (Zevalin)FDA Link 04/2003 - 05/2002
2	VaccinesIBA 05/2024 - 01/2022
2	tocilizumab (atlizumab)FDA Link 01/2024 - 01/2021
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 10/2020
2	Interleukin-15 (Interleukin 15)IBA 01/2021 - 11/2020
2	ALT-803IBA 01/2021 - 02/2016
2	CytokinesIBA 11/2020 - 01/2019
2	CreatinineIBA 11/2020 - 06/2014
2	ofatumumab FDA Link 10/2019 - 01/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019 - 08/2015
2	Immune Checkpoint InhibitorsIBA 01/2019 - 11/2018
2	Chlorambucil (Leukeran)FDA Link 01/2018 - 12/2015
2	Methotrexate (Mexate)FDA LinkGeneric 10/2016 - 06/2014
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2016 - 03/2011
2	Mechlorethamine (Nitrogen Mustard)FDA Link 06/2015 - 04/2013

Therapy/Procedure

64	Therapeutics 04/2024 - 06/2002
42	Drug Therapy (Chemotherapy) 10/2023 - 02/2002
14	Immunotherapy 10/2023 - 05/2002
12	Radiotherapy 04/2024 - 02/2002
10	Stem Cell Transplantation 04/2024 - 12/2009
4	Salvage Therapy 12/2021 - 08/2003
4	Combination Drug Therapy (Combination Chemotherapy) 10/2016 - 08/2003
4	Radioimmunotherapy 04/2009 - 05/2002
2	Induction Chemotherapy 10/2023 - 10/2016
2	Injections 01/2022 - 10/2018
2	Aftercare (After-Treatment) 10/2019 - 05/2011